Paramyotonia congenita is a rare genetic disease characterized by stiffness of skeletal muscles. It is caused by mutations in the sodium channel gene SCN4A, which is associated with other rare muscle diseases. The frequency of this disease is not well-known, but it is thought to affect a small number of people worldwide.

Clinicaltrials.gov provides information about ongoing clinical trials, research studies, and genetic testing options for paramyotonia congenita. These resources can help patients and their families to learn more about the disease and find additional support. The OMIM database and PubMed are also helpful references for scientific articles and genetic information about paramyotonia congenita.

The Paramyotonia Congenita Center offers advocacy and support for people with this disease and their families. They provide information on genetic testing, inheritance patterns, and more. The center also collaborates with researchers to conduct studies and advance the understanding of paramyotonia congenita.

Genetic testing is often used to diagnose paramyotonia congenita. Testing can identify the specific mutations in the SCN4A gene that cause the disease. This information can be used to guide treatment and management of symptoms. The Genetic Testing Registry is a useful tool for finding laboratories that offer testing for paramyotonia congenita.

In conclusion, paramyotonia congenita is a rare genetic disease that causes stiffness of skeletal muscles. It is associated with mutations in the SCN4A gene and is often diagnosed through genetic testing. Ongoing research and clinical trials provide hope for better understanding and treatment of this condition. Support resources are available to help patients and their families navigate the challenges of living with paramyotonia congenita.

Frequency

Paramyotonia congenita is a rare genetic disease that affects the muscles, causing stiffness. The frequency of this condition is not well documented, but it is considered a rare disease. Paramyotonia congenita is associated with mutations in genes related to sodium channels in muscle cells.

The average length of the portion of a doctor appointment in which the patient actually sees the doctor is up from previous years, rising by about 12 seconds per year, according to Reuters. However, 60% of physicians report dissatisfaction with the amount of time they spend with their patients, athenaInsight Many doctors now spend more time on paperwork than seeing patients, and a primary care physician who spends 5 minutes of face-to-face time with a patient will spend another 19.3 minutes, on average, working on that patient’s electronic health records (EHRs).

While the exact frequency of paramyotonia congenita is unknown, it is estimated to affect a small number of people worldwide. This condition is usually inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.

Research studies and clinical trials are ongoing to learn more about the frequency and other information about paramyotonia congenita. These studies can provide valuable resources and additional support for people affected by this rare genetic disease.

If you would like to learn more about the frequency and inheritance of paramyotonia congenita, you can refer to the following resources:

• OMIM – Online Mendelian Inheritance in Man: This catalog provides detailed information on genetic diseases, including paramyotonia congenita.
• ClinicalTrials.gov: This website lists ongoing clinical trials that are studying paramyotonia congenita and other related diseases.
• PubMed: Search for scientific articles on paramyotonia congenita to find more information on the frequency and causes of this condition.

Advocacy and patient support organizations can also provide valuable resources and support for individuals and families affected by paramyotonia congenita. These organizations can offer information on genetic testing, research studies, and more.

References:

1. “Paramyotonia Congenita.” Genetics Home Reference, U.S. National Library of Medicine, ghr.nlm.nih.gov/condition/paramyotonia-congenita.
2. “Paramyotonia Congenita.” National Organization for Rare Disorders, www.rarediseases.org/rare-diseases/paramyotonia-congenita.

Causes

Paramyotonia congenita is a genetic condition that is caused by mutations in the SCN4A gene. This gene provides instructions for making a protein that is involved in the movement of sodium ions in muscle cells. Mutations in this gene can disrupt the normal function of the protein, leading to muscle stiffness and other symptoms of the disorder.

Paramyotonia congenita is inherited in an autosomal dominant pattern, which means that a person only needs to inherit one copy of the mutated gene to develop the condition. In some cases, the condition can also be caused by de novo mutations, which occur in people with no family history of the disorder.

There are additional genes that have been associated with a similar condition called hyperkalemic periodic paralysis, which shares some symptoms with paramyotonia congenita. These genes include SCN4A, CACNA1S, and SCN4B.

The frequency of paramyotonia congenita is unknown, but it is estimated to affect around 1 in 100,000 people. It is more common in individuals of European descent.

Testing for mutations in the SCN4A gene can be used to confirm a diagnosis of paramyotonia congenita. Genetic testing may also be used to determine the inheritance pattern of the condition in a family.

For more information about the genetic causes of paramyotonia congenita, you can visit the OMIM catalog of genetic diseases (OMIM #168300) or search for scientific articles on PubMed. Other resources, such as the Genetic and Rare Diseases Information Center and clinicaltrials.gov, may also have additional information on research studies and clinical trials related to this condition.

Learn more about the gene associated with Paramyotonia congenita

Paramyotonia congenita is a rare genetic condition characterized by muscle stiffness and pain. It is associated with mutations in the gene SCN4A, which encodes a sodium channel protein that is critical for muscle function.

Paramyotonia congenita can be inherited in an autosomal dominant manner, meaning that a person with one copy of the mutated gene has a 50% chance of passing it on to each of their children. Some individuals with the condition may have additional mutations in the SCN4A gene, further contributing to the severity of their symptoms.

For people with Paramyotonia congenita, the stiffness and muscle pain can be triggered by factors such as cold temperatures, exercise, or emotional stress. Symptoms typically improve with rest and may worsen with repeated activity.

To confirm a diagnosis of Paramyotonia congenita, genetic testing can be performed to detect mutations in the SCN4A gene. Testing can also help identify other genetic diseases associated with muscle stiffness and inform treatment plans.

For more information on Paramyotonia congenita, its causes, and available support and resources, you can visit the following:

• The Online Mendelian Inheritance in Man (OMIM) database: provides scientific information about genes and genetic diseases
• The Genetic and Rare Diseases Information Center: offers information, resources, and support for rare diseases
• ClinicalTrials.gov: a database of clinical studies and research articles on Paramyotonia congenita
• Advocacy organizations like the Paramyotonia Congenita Center: dedicated to supporting patients and promoting research on the condition

References used:

1. “Paramyotonia Congenita” – Genetics Home Reference, U.S. National Library of Medicine, https://ghr.nlm.nih.gov/condition/paramyotonia-congenita
2. “Paramyotonia congenita” – OMIM database, Johns Hopkins University, https://omim.org/entry/168300
3. “Paramyotonia Congenita” – PubMed, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/?term=Paramyotonia Congenita
4. “Paramyotonia Congenita” – Genetic and Rare Diseases Information Center, U.S. National Library of Medicine, https://rarediseases.info.nih.gov/diseases/2078/paramyotonia-congenita

Inheritance

Paramyotonia congenita is a genetic disorder associated with mutations in the SCN4A gene. This gene provides instructions for making a protein that plays a critical role in the normal function of sodium channels in muscle cells. Sodium channels are involved in the movement of sodium ions into and out of cells, which is necessary for the normal electrical signaling in muscles.

The inheritance of paramyotonia congenita is autosomal dominant, which means that a person with one mutated copy of the SCN4A gene in each cell is affected by the condition. In most cases, an affected person inherits the mutation from one affected parent. However, in some cases, the condition may occur for the first time in a family due to a new mutation in the gene.

Genetic testing can be used to confirm the diagnosis of paramyotonia congenita and to identify the specific mutation in the SCN4A gene. This can be helpful for genetic counseling and family planning, as it can provide information about the chances of passing the condition on to future generations.

For people with paramyotonia congenita, there are resources available to learn more about the disease and to find support. The Online Mendelian Inheritance in Man (OMIM) and the Genetic and Rare Diseases Information Center (GARD) are two databases that provide information and resources about genetic conditions like paramyotonia congenita.

In addition to genetic testing, clinical trials and research studies are often conducted to learn more about paramyotonia congenita and develop new treatments. PubMed is a database that provides access to scientific articles and research studies related to the condition, and clinicaltrials.gov is a resource for finding information about ongoing clinical trials.

Patient advocacy and support groups can also be valuable resources for people with paramyotonia congenita and their families. These groups can provide information, support, and opportunities to connect with others who are affected by the condition.

Overall, while paramyotonia congenita is a rare genetic condition, there are resources and support available for people living with the disease. Genetic testing, research studies, and patient advocacy organizations can all provide valuable information and support for individuals and families affected by this condition.

Other Names for This Condition

Paramyotonia congenita, also known as PMC, is a rare genetic condition that affects the muscles and causes stiffness. It is often inherited in an autosomal dominant pattern.

Paramyotonia congenita is also sometimes referred to as Eulenburg disease, since the first descriptions of the condition were made by Heinrich Eulenburg in 1886.

Other names used to describe this condition include:

• Myotonia fluctuans
• Myotonia permanens
• Hyperkalemic periodic paralysis

These names reflect different aspects and presentations of the condition, as well as the genetic mutations associated with it.

Genes such as SCN4A and CACNA1S are known to cause paramyotonia congenita when they have specific mutations.

People with paramyotonia congenita may experience muscle stiffness, particularly in cold temperatures or after exercising. The stiffness can improve with warming the muscles or rest.

For more information about this condition, genetic testing, and support resources, you may find the following websites and references helpful:

• OMIM (Online Mendelian Inheritance in Man): A comprehensive database of genes and genetic diseases, including paramyotonia congenita.
• PubMed: A search engine for scientific articles and studies on paramyotonia congenita.
• Advocacy organizations and patient support groups: These organizations provide additional information, resources, and support for individuals and families affected by rare genetic diseases like paramyotonia congenita.
• ClinicalTrials.gov: This website provides information about ongoing clinical trials and research related to paramyotonia congenita.

By learning more about the condition, the genes involved, and the frequency in which it occurs, researchers and clinicians can continue to develop better diagnostic tools, treatment options, and support for individuals with paramyotonia congenita.

Additional Information Resources

If you would like to learn more about Paramyotonia Congenita, here are some additional resources that you may find helpful:

• Inheritance: Paramyotonia Congenita is a rare genetic condition that is inherited in an autosomal dominant manner. This means that only one copy of the mutated gene is needed to develop the condition. If one parent has the condition, there is a 50% chance that their child will inherit it as well.
• Genetic Testing: Genetic testing can be used to identify the specific gene mutations that cause Paramyotonia Congenita. This information can be helpful for diagnosing the condition and for providing more accurate information about the prognosis and treatment options.
• Sodium channel genes: Paramyotonia Congenita is caused by mutations in genes that encode sodium channels in muscle cells. These mutations can lead to increased muscle stiffness and difficulty with voluntary muscle movements.
• Rare Disease: Paramyotonia Congenita is considered a rare disease, with a frequency estimated to be between 1 in 100,000 and 1 in 500,000 individuals. Due to its rarity, there is limited scientific research and information available about this condition.
• Research Studies: There have been some research studies conducted on Paramyotonia Congenita, but more research is needed to better understand the causes, underlying mechanisms, and potential treatments for this condition. PubMed is a great resource for finding articles and research studies about Paramyotonia Congenita.
• Patient Support: For individuals and families affected by Paramyotonia Congenita, there are support resources available. These resources can provide information, support, and advocacy for people living with this condition.

If you would like to find more information about Paramyotonia Congenita, here are some additional resources that you may find helpful:

• OMIM: Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. You can search for Paramyotonia Congenita in OMIM to find more detailed information about the genetic causes, clinical features, and management of this condition.
• ClinicalTrials.gov: ClinicalTrials.gov is a comprehensive database of clinical research studies that are ongoing or completed. You can search for Paramyotonia Congenita on ClinicalTrials.gov to find information about any current or upcoming clinical trials that may be relevant to this condition.

Genetic Testing Information

Genetic testing plays a crucial role in the diagnosis and management of paramyotonia congenita. This condition is caused by mutations in the SCN4A gene, which is responsible for making a protein called sodium channel alpha subunit, muscle type. These mutations lead to muscle stiffness and other symptoms associated with the rare disease.

Genetic testing can help confirm a diagnosis of paramyotonia congenita by identifying mutations in the SCN4A gene. It is a valuable tool for physicians and genetic counselors to provide accurate information about the inheritance pattern, risks to family members, and appropriate treatment options.

There are several resources available to support genetic testing for paramyotonia congenita. The OMIM database provides detailed information about the genes, genetic mutations, and clinical features associated with this condition. PubMed, a widely used database of scientific articles, can be used to find additional research studies and references on this topic.

Patient advocacy groups and genetic centers may also provide information and support for individuals and families affected by paramyotonia congenita. These organizations often maintain a catalog of genetic tests available for this and other rare diseases, as well as resources for patients to learn more about the condition and available treatment options.

It is important to note that genetic testing is not only used for diagnostic purposes but also for research studies and clinical trials. By identifying specific genetic mutations in paramyotonia congenita, researchers can gain a better understanding of the disease mechanisms and develop targeted therapies.

In summary, genetic testing is a valuable tool in the diagnosis and management of paramyotonia congenita. It provides crucial information about the genetic causes and inheritance patterns of the condition, as well as helps in research studies and development of new treatments. Patients and their families can rely on the support from patient advocacy groups, genetic centers, and scientific resources to access the necessary genetic testing and learn more about this rare disease.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center is a center that provides information about the frequency, causes, associated genes, and inheritance of rare genetic diseases. It offers resources for people with rare diseases, their families, healthcare providers, and researchers.

One rare genetic disease that the center provides information on is Paramyotonia congenita. This is a condition that causes muscle stiffness and is associated with mutations in the sodium channel gene. People with this rare condition may experience muscle stiffness that worsens with exercise or in cold temperatures.

To diagnose Paramyotonia congenita and other rare genetic diseases, genetic testing can be used to identify mutations in specific genes. This testing can be done through clinical trials or through scientific studies. By learning more about the genes associated with these rare diseases, researchers can better understand the causes and develop potential treatments.

The Genetic and Rare Diseases Information Center offers additional resources for those affected by rare genetic diseases. These resources include information on advocacy groups, support organizations, and patient registries. These resources can provide support and connect individuals with others who have similar conditions.

For more information about Paramyotonia congenita and other rare diseases, the center provides references to scientific articles, research studies, and other resources. These references can be found on PubMed, OMIM, and other genetic databases.

Patient Support and Advocacy Resources

Paramyotonia congenita is a rare genetic condition characterized by muscle stiffness and weakness. It is caused by mutations in the SCN4A gene, which is responsible for the production of a sodium channel protein. This protein is involved in the function of muscles, and mutations in the gene can lead to abnormal muscle stiffness.

For people with paramyotonia congenita and other rare diseases, patient support and advocacy resources can provide valuable information and assistance. These resources can help patients and their families learn more about the condition, find support from others who are dealing with the same challenges, and access the latest research and clinical trials.

Genetic Testing and Inheritance

Genetic testing can be used to confirm a diagnosis of paramyotonia congenita and to identify the specific mutations in the SCN4A gene. Testing may also be used to determine whether other genes are involved in causing the condition.

Paramyotonia congenita is inherited in an autosomal dominant pattern, which means that an affected person has a 50% chance of passing the condition on to each of their children.

Patient Support Resources

There are several organizations and online resources that provide support and information for people with paramyotonia congenita and other rare diseases. Some of these resources include:

• The Genetic and Rare Diseases Information Center (GARD) is a resource that provides information about genetic conditions, including paramyotonia congenita. GARD offers a directory of patient support organizations and additional resources for rare diseases.
• OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of human genes and genetic disorders. The catalog includes information about the SCN4A gene and paramyotonia congenita.
• The National Center for Advancing Translational Sciences provides resources for rare diseases, including information about ongoing research and clinical trials. Their website includes links to clinicaltrials.gov and PubMed, which can be used to search for scientific articles and studies related to paramyotonia congenita.

These resources can be used to learn more about paramyotonia congenita, find support from others who are dealing with the same condition, and stay up to date on the latest research and treatment options. They can also help connect individuals with doctors and researchers who specialize in rare diseases and provide personalized care.

Research Studies from ClinicalTrialsgov

Research studies from ClinicalTrialsgov provide valuable information about paramyotonia congenita, a rare genetic disease characterized by muscle stiffness.

Paramyotonia congenita, also known as hyperkalemic periodic paralysis, is caused by mutations in the SCN4A gene, which is responsible for encoding a sodium channel involved in muscle contraction. This condition is inherited in an autosomal dominant pattern, meaning that a person with only one affected copy of the gene can develop the disease.

ClinicalTrialsgov is a comprehensive catalog of research studies and clinical trials conducted worldwide. It offers resources for patients, advocacy groups, and healthcare providers seeking information on rare diseases like paramyotonia congenita.

Research studies on paramyotonia congenita focus on understanding the underlying genetic causes, developing new treatments, and improving the quality of life for people with the condition. These studies may investigate the frequency of specific genetic mutations, explore the associated symptoms and complications, or test new medications or interventions.

Through ClinicalTrialsgov, people can learn about ongoing research studies and clinical trials for paramyotonia congenita. This information can help patients find additional support, connect with researchers, and stay updated on the latest advancements in the field.

In addition to ClinicalTrialsgov, other resources like OMIM (Online Mendelian Inheritance in Man), PubMed, and genetic testing centers provide valuable information about paramyotonia congenita. These resources offer articles, references, and genetic testing options for individuals and healthcare professionals seeking more information about this rare disease.

Studying paramyotonia congenita not only contributes to the understanding and treatment of this specific condition but also provides insights into other related muscle diseases and genetic disorders.

Catalog of Genes and Diseases from OMIM

Additional information about genes and diseases can be found in the catalog from OMIM (Online Mendelian Inheritance in Man). OMIM is a scientific resource that provides comprehensive information on genetic conditions and the associated genes.

For patients and healthcare providers, OMIM offers testing information, clinical trials, and references to scientific articles. It also provides information on the inheritance pattern and frequency of the disease.

The catalog includes genes associated with various rare diseases, including Paramyotonia Congenita. Paramyotonia Congenita is a genetic condition characterized by muscle stiffness and weakness. The disease is caused by mutations in the sodium gene.

If you want to learn more about Paramyotonia Congenita or other rare diseases, you can search the catalog using gene names or disease names. The catalog provides information on the genetic basis of these conditions and references for further reading.

OMIM is a valuable resource for genetic testing laboratories, researchers, and advocacy groups. It provides up-to-date information on genes and diseases, supports research efforts, and promotes advocacy for rare genetic conditions.

For more information, you can visit the OMIM website or search OMIM using the gene or disease name. OMIM references can also be found in PubMed and clinicaltrialsgov.

This catalog serves as a central repository for genetic information, providing a comprehensive overview of genes and diseases. It is a valuable resource for scientists, healthcare providers, and patients seeking information on rare genetic conditions.

Scientific Articles on PubMed

Paramyotonia congenita is a rare genetic disease associated with mutations in sodium channel genes. This condition causes stiffness in the muscles, which can make it difficult for affected individuals to move and perform daily activities. Paramyotonia congenita is inherited in an autosomal dominant manner, meaning that a person only needs one copy of the mutated gene to develop the condition.

To learn more about paramyotonia congenita, researchers and healthcare professionals can consult the scientific articles available on PubMed. PubMed is a database that catalogues a wide range of scientific literature, including articles about rare diseases like paramyotonia congenita. By reading these articles, researchers can gain a better understanding of the genetic causes of the condition, learn about the latest research and studies, and find references to additional resources and testing options.

Some of the articles available on PubMed provide information about specific genes associated with paramyotonia congenita. For example, one study identified mutations in the SCN4A gene as a common cause of the condition. Other studies have explored the clinical features and inheritance patterns of paramyotonia congenita.

In addition to PubMed, the Online Mendelian Inheritance in Man (OMIM) database can also be a valuable resource for information about paramyotonia congenita. OMIM provides detailed information about genetic disorders, including a summary of the condition, genetic testing options, gene names and aliases, and references to relevant articles and studies.

Patient advocacy and support groups can also provide helpful resources and information about paramyotonia congenita. These organizations can connect patients and families with others affected by the condition, offer support and guidance, and provide updates on the latest research and clinical trials.

Overall, the scientific articles available on PubMed and other resources can provide valuable insights into paramyotonia congenita. By staying informed and up to date on the latest research, healthcare professionals can provide the best possible care for patients with this rare condition.

References

• OMIM: Online Mendelian Inheritance in Man. Paramyotonia Congenita. [cited 2021 Apr 1]. Available from: https://www.omim.org/entry/168300.
• Genetics Home Reference. US National Library of Medicine. Paramyotonia Congenita. [cited 2021 Apr 1]. Available from: https://ghr.nlm.nih.gov/condition/paramyotonia-congenita.
• PubMed. Paramyotonia congenita. [cited 2021 Apr 1]. Available from: https://pubmed.ncbi.nlm.nih.gov/?term=paramyotonia+congenita.
• ClinicalTrials.gov. US National Library of Medicine. Paramyotonia congenita. [cited 2021 Apr 1]. Available from: https://clinicaltrials.gov/ct2/results?cond=paramyotonia+congenita.
• Genetic and Rare Diseases Information Center. US Department of Health and Human Services. Paramyotonia congenita. [cited 2021 Apr 1]. Available from: https://rarediseases.info.nih.gov/diseases/1713/paramyotonia-congenita.